Gilead Sciences (GILD) stock forecast for 2026. Forecast tables and graphs.







Your Path to Profits: The Best Trading Platforms for New Traders

October 3, 2024 Your Path to Profits: The Best Trading Platforms for New Traders

Welcome to trading! If you’re a newb looking to get to financial freedom, choosing the right trading platform is step one. With so…
Mastering Trading Indicators: Your Essential Toolkit For Success

October 3, 2024 Mastering Trading Indicators: Your Essential Toolkit For Success

Often investors struggle to identify profitable trades consistently. Trading indicators provide essential data to guide trading decisions. This article explains key indicators and…
Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…

Gilead Sciences (GILD) stock forecast for 2026

Updated: October 12, 2024 (15:36)

Sector: Healthcare

The share price of Gilead Sciences, Inc. (GILD) now

What analysts predict: $84.43
52-week High/Low: $86.85 / $60.75

50/200 Day Moving Average: $79.83 / $73.92

This figure corresponds to the Average Price over the previous 50/200 days. For Gilead Sciences stocks, the 50-day moving average is the resistance level today.

For Gilead Sciences stocks, the 200-day moving average is the resistance level today.

Are you interested in Gilead Sciences, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Gilead Sciences stock price in 2026. How much will one Gilead Sciences share be worth in 2026? Is it worth taking profit / loss on GILD stock now or waiting? What are analysts' forecasts for Gilead Sciences stock?

We forecast Gilead Sciences stock performance using neural networks based on historical data on GILD stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

Gilead Sciences, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Gilead Sciences analysts is $84.43. Today 200 Day Moving Average is the support level (73.92 $). 50 Day Moving Average is the support level (79.83 $).




Historical and forecast chart of Gilead Sciences, Inc. stock

The chart below shows the historical price of Gilead Sciences stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the GILD stock price can be found in the table below.


Gilead Sciences is an American biopharmaceutical company that discovers, develops and markets innovative medicines. For many years since the firm opened, they have specialized mainly in antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C and influenza. The company is headquartered in Foster City, California, but has offices in North America, Europe and Australia.

Gilead Sciences was founded in June 1987 by a young physician, Michael Riordan. Michael worked with three key scientific advisors to start the company – Peter Derwan of the California Institute of Technology, Doug Melton of Harvard, and Harold Weintraub of the Fred Hutchinson Cancer Research Center. Riordan served as CEO from inception until 1996. He was most interested in the antiviral business, as he contracted dengue himself. In 2006, the company made two acquisitions, which allowed it to expand into not only antiviral drugs, but also drugs in the field of cardiovascular and respiratory diseases.

Official site of the company

Trending Themes in the Healthcare Sector

Gilead Sciences (GILD) Forecast for 2026

Month Target Pes. Opt. Vol., %
Jan 84.28 81.21 87.57 7.27 %
Feb 82.30 79.13 84.36 6.20 %
Mar 81.27 78.10 82.13 4.90 %
Apr 82.25 79.25 85.50 7.31 %
May 83.19 80.16 85.52 6.27 %
Jun 83.53 82.15 86.58 5.11 %
Jul 80.85 77.74 83.04 6.38 %
Aug 79.08 77.89 80.06 2.72 %
Sep 77.45 76.56 79.24 3.37 %
Oct 79.35 76.97 80.19 4.01 %
Nov 80.42 77.69 81.51 4.69 %
Dec 84.32 81.25 87.23 6.86 %

Gilead Sciences information and performance

Gilead Sciences Address

333 LAKESIDE DR, FOSTER CITY, CA, US

Market Capitalization: 105 761 890 000 $

Market capitalization of the Gilead Sciences, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of GILD shares in the company outstanding by the market price of one share.

EBITDA: 13 462 000 000 $

EBITDA of Gilead Sciences is earnings before interest, income tax and depreciation of assets.

PE Ratio: 103.6

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 0.504

Price/earnings to growth

DPS: 3.04

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0363

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 0.82

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0.554
Quarterly Revenue Growth YOY: 0.054
Trailing PE: 103.6

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 11.81

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 4.531

Enterprise Value (EV) /Revenue

EV To EBITDA: 23.91

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 1244990000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Gilead Sciences price target for 2026 by month


Target values for the price of one Gilead Sciences share for Jan 2026.

The weighted average target price per Gilead Sciences share in Jan 2026 is: 84.28.
In Jan, the Positive dynamics for Gilead Sciences, Inc. shares will prevail with possible monthly volatility of 7.267% volatility is expected.
Pessimistic target level: 81.21
Optimistic target level: 87.57

Target values for the price of one Gilead Sciences share for Feb 2026.

The weighted average target price per Gilead Sciences share in Feb 2026 is: 82.30.
In Feb, the Negative dynamics for Gilead Sciences, Inc. shares will prevail with possible monthly volatility of 6.195% volatility is expected.
Pessimistic target level: 79.13
Optimistic target level: 84.36

Target values for the price of one Gilead Sciences share for Mar 2026.

The weighted average target price per Gilead Sciences share in Mar 2026 is: 81.27.
In Mar, the Negative dynamics for Gilead Sciences, Inc. shares will prevail with possible monthly volatility of 4.899% volatility is expected.
Pessimistic target level: 78.10
Optimistic target level: 82.13

Target values for the price of one Gilead Sciences share for Apr 2026.

The weighted average target price per Gilead Sciences share in Apr 2026 is: 82.25.
In Apr, the Positive dynamics for Gilead Sciences, Inc. shares will prevail with possible monthly volatility of 7.311% volatility is expected.
Pessimistic target level: 79.25
Optimistic target level: 85.50

Target values for the price of one Gilead Sciences share for May 2026.

The weighted average target price per Gilead Sciences share in May 2026 is: 83.19.
In May, the Positive dynamics for Gilead Sciences, Inc. shares will prevail with possible monthly volatility of 6.274% volatility is expected.
Pessimistic target level: 80.16
Optimistic target level: 85.52

Target values for the price of one Gilead Sciences share for Jun 2026.

The weighted average target price per Gilead Sciences share in Jun 2026 is: 83.53.
In Jun, the Positive dynamics for Gilead Sciences, Inc. shares will prevail with possible monthly volatility of 5.113% volatility is expected.
Pessimistic target level: 82.15
Optimistic target level: 86.58

Target values for the price of one Gilead Sciences share for Jul 2026.

The weighted average target price per Gilead Sciences share in Jul 2026 is: 80.85.
In Jul, the Negative dynamics for Gilead Sciences, Inc. shares will prevail with possible monthly volatility of 6.378% volatility is expected.
Pessimistic target level: 77.74
Optimistic target level: 83.04

Target values for the price of one Gilead Sciences share for Aug 2026.

The weighted average target price per Gilead Sciences share in Aug 2026 is: 79.08.
In Aug, the Negative dynamics for Gilead Sciences, Inc. shares will prevail with possible monthly volatility of 2.716% volatility is expected.
Pessimistic target level: 77.89
Optimistic target level: 80.06

Target values for the price of one Gilead Sciences share for Sep 2026.

The weighted average target price per Gilead Sciences share in Sep 2026 is: 77.45.
In Sep, the Negative dynamics for Gilead Sciences, Inc. shares will prevail with possible monthly volatility of 3.372% volatility is expected.
Pessimistic target level: 76.56
Optimistic target level: 79.24

Target values for the price of one Gilead Sciences share for Oct 2026.

The weighted average target price per Gilead Sciences share in Oct 2026 is: 79.35.
In Oct, the Positive dynamics for Gilead Sciences, Inc. shares will prevail with possible monthly volatility of 4.008% volatility is expected.
Pessimistic target level: 76.97
Optimistic target level: 80.19

Target values for the price of one Gilead Sciences share for Nov 2026.

The weighted average target price per Gilead Sciences share in Nov 2026 is: 80.42.
In Nov, the Positive dynamics for Gilead Sciences, Inc. shares will prevail with possible monthly volatility of 4.687% volatility is expected.
Pessimistic target level: 77.69
Optimistic target level: 81.51

Target values for the price of one Gilead Sciences share for Dec 2026.

The weighted average target price per Gilead Sciences share in Dec 2026 is: 84.32.
In Dec, the Positive dynamics for Gilead Sciences, Inc. shares will prevail with possible monthly volatility of 6.863% volatility is expected.
Pessimistic target level: 81.25
Optimistic target level: 87.23



Gilead Sciences (GILD) stock dividend

Gilead Sciences last paid dividends on 09/13/2024. The next scheduled payment will be on 09/27/2024. The amount of dividends is $3.04 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.